Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms.

[1]  M. Kimura,et al.  An introduction to population genetics theory , 1971 .

[2]  E. Anderson.  Hudson et al. , 1977 .

[3]  W. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.

[4]  S. Wilton,et al.  Apolipoprotein E and Alzheimer's disease , 1995 .

[5]  D. Cooper,et al.  Human Gene Mutation Database , 1996, Human Genetics.

[6]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[7]  B Müller-Myhsok,et al.  Genetic analysis of complex diseases. , 1997, Science.

[8]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[9]  F. Guengerich.  The Environmental Genome Project: functional analysis of polymorphisms. , 1998, Environmental health perspectives.

[10]  M. King,et al.  Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[12]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[13]  S T Sherry,et al.  Use of molecular variation in the NCBI dbSNP database , 2000, Human mutation.

[14]  M. Nachman,et al.  Estimate of the mutation rate per nucleotide in humans. , 2000, Genetics.

[15]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[16]  J. Pritchard.  Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.

[17]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[18]  E. Lander,et al.  On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.

[19]  Damian Labuda,et al.  Assessing DNA sequence variations in human ESTs in a phylogenetic context using high-density oligonucleotide arrays. , 2002, Genomics.

[20]  Dan Graur,et al.  Ratios of radical to conservative amino acid replacement are affected by mutational and compositional factors and may not be indicative of positive Darwinian selection. , 2002, Molecular biology and evolution.

[21]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[22]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[23]  Tracy Webb,et al.  SNPs: can genetic variants control cancer susceptibility? , 2002, Journal of the National Cancer Institute.

[24]  J. Pritchard,et al.  The allelic architecture of human disease genes: common disease-common variant...or not? , 2002, Human molecular genetics.

[25]  R. Folz,et al.  Oxidative stress and inflammation contribute to lung toxicity after a common breast cancer chemotherapy regimen. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[26]  D. Altshuler,et al.  The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. , 2003, Annual review of genomics and human genetics.

[27]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[28]  S. Gabriel,et al.  Quality and completeness of SNP databases , 2003, Nature Genetics.

[29]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[30]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[31]  Alexey S Kondrashov,et al.  Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases , 2003, Human mutation.

[32]  Lars Bolund,et al.  A population threshold for functional polymorphisms. , 2003, Genome research.

[33]  P. Stenson,et al.  Human Gene Mutation Database (HGMD , 2003 .

[34]  P. Tam.  The International HapMap Consortium. The International HapMap Project (Co-PI of Hong Kong Centre which responsible for 2.5% of genome) , 2003 .

[35]  W. G. Hill,et al.  Influence of Dominance, Leptokurtosis and Pleiotropy of Deleterious Mutations on Quantitative Genetic Variation at Mutation-Selection Balance , 2004, Genetics.

[36]  Steven J. Schrodi,et al.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.

[37]  Jorng-Tzong Horng,et al.  Identifying the combination of genetic factors that determine susceptibility to cervical cancer , 2004, Proceedings. Fourth IEEE Symposium on Bioinformatics and Bioengineering.

[38]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[39]  M. W. Foster,et al.  Integrating ethics and science in the International HapMap Project , 2004, Nature Reviews Genetics.

[40]  Brian Staats,et al.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..

[41]  J. Denecke,et al.  An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense‐mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG‐Id) , 2004, Human mutation.

[42]  J. Ivanovich,et al.  Severe subacute GM2 gangliosidosis caused by an apparently silent HEXA mutation (V324V) that results in aberrant splicing and reduced HEXA mRNA , 2004, American journal of medical genetics. Part A.

[43]  Samuel H. Wilson,et al.  The Environmental Genome Project: phase I and beyond. , 2004, Molecular interventions.

[44]  Charles R Cantor,et al.  The Use of Genetic SNPs as New Diagnostic Markers in Preventive Medicine , 2005, Annals of the New York Academy of Sciences.

[45]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[46]  Anthony J Brookes,et al.  Linkage disequilibrium patterns vary substantially among populations , 2005, European Journal of Human Genetics.

[47]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[48]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[49]  C. Burge,et al.  Linking C5 Deficiency to an Exonic Splicing Enhancer Mutation , 2005, The Journal of Immunology.

[50]  D. Carlini,et al.  Synonymous SNPs Provide Evidence for Selective Constraint on Human Exonic Splicing Enhancers , 2005, Journal of Molecular Evolution.

[51]  Sean D. Mooney,et al.  Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis , 2005, Briefings Bioinform..

[52]  N. Butta,et al.  Type I Glanzmann thrombasthenia caused by an apparently silent β3 mutation that results in aberrant splicing and reduced β3 mRNA , 2005, Thrombosis and Haemostasis.

[53]  D. Goldstein,et al.  Association of genetic loci: Replication or not, that is the question , 2004, Neurology.

[54]  Jack A. Taylor,et al.  How Well Do HapMap Haplotypes Identify Common Haplotypes of Genes? A Comparison with Haplotypes of 334 Genes Resequenced in the Environmental Genome Project , 2006, Cancer Epidemiology Biomarkers & Prevention.

[55]  Jonathan C. Cohen,et al.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. , 2006, American journal of human genetics.

[56]  Genica,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium , 2006 .

[57]  Margaret A. Pericak-Vance,et al.  Genetic Analysis of Complex Disease , 2006 .

[58]  C. Amos,et al.  Strength of the purifying selection against different categories of the point mutations in the coding regions of the human genome. , 2006, Human molecular genetics.

[59]  Hugues Sicotte,et al.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes , 2005, Nucleic Acids Res..

[60]  Paul D.P. Pharoah,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.

[61]  D. Clayton,et al.  A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region , 2006, Nature Genetics.

[62]  [Screening and analysis of coding SNPs of HLA-DQA1 gene involved in susceptibility for cervical cancer]. , 2006, Ai zheng = Aizheng = Chinese journal of cancer.

[63]  Margaret R Karagas,et al.  Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. , 2006, Carcinogenesis.

[64]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.

[65]  Shamil R Sunyaev,et al.  Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.

[66]  Marek Kimmel,et al.  Simulations Provide Support for the Common Disease–Common Variant Hypothesis , 2007, Genetics.

[67]  Doheon Lee,et al.  SNP@Ethnos: a database of ethnically variant single-nucleotide polymorphisms , 2006, Nucleic Acids Res..